First Time Loading...

Nektar Therapeutics
NASDAQ:NKTR

Watchlist Manager
Nektar Therapeutics Logo
Nektar Therapeutics
NASDAQ:NKTR
Watchlist
Price: 1.83 USD 3.39% Market Closed
Updated: May 16, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement
|
Revenue Breakdown

Balance Sheet

396m
-0.5%
Assets
Growth Rates:
1 Year
-29%
3 Years
-73%
5 Years
-82%
7 Years
-25%
10 Years
-19%
269.3m
+0.8%
Liabilities
Growth Rates:
1 Year
-16%
3 Years
-42%
5 Years
-49%
7 Years
-44%
10 Years
-46%
126.7m
-3%
Equity
Growth Rates:
1 Year
-47%
3 Years
-87%
5 Years
-92%
7 Years
+183%
10 Years
-

Balance Sheet Decomposition
Nektar Therapeutics

396m
Assets
269.3m
Liabilities
396m
Assets
269.3m
Liabilities
Current Assets 319.8m
Cash & Short-Term Investments 289.2m
Receivables 3.6m
Other Current Assets 27m
Non-Current Assets 76.2m
Long-Term Investments 36.8m
PP&E 34.7m
Other Non-Current Assets 4.7m
Current Liabilities 52.4m
Accounts Payable 8.8m
Accrued Liabilities 43.6m
Non-Current Liabilities 216.9m
Other Non-Current Liabilities 216.9m

Balance Sheet
Nektar Therapeutics

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
12
56
60
5
195
96
199
25
88
35
Cash Equivalents
12
56
60
5
195
96
199
25
88
35
Short-Term Investments
226
253
330
291
1 140
1 229
863
709
417
268
Total Receivables
4
20
16
5
43
37
39
23
6
1
Accounts Receivables
4
20
16
5
43
37
39
23
6
1
Other Receivables
0
0
0
0
0
0
0
0
0
0
Inventory
13
11
11
11
11
13
15
16
19
16
Other Current Assets
34
10
10
15
48
47
22
23
16
10
Total Current Assets
288
350
426
327
1 438
1 422
1 138
796
546
331
PP&E Net
70
71
66
48
49
199
186
178
86
37
PP&E Gross
70
71
66
48
49
199
186
178
86
37
Accumulated Depreciation
94
103
111
115
121
128
139
148
125
87
Goodwill
77
77
77
77
77
77
77
77
77
0
Long-Term Investments
0
0
0
57
583
279
137
65
0
26
Other Long-Term Assets
7
1
1
1
4
1
2
3
2
5
Other Assets
77
77
77
77
77
77
77
77
77
0
Total Assets
442
N/A
499
+13%
569
+14%
509
-11%
2 150
+323%
1 977
-8%
1 539
-22%
1 117
-27%
711
-36%
398
-44%
Liabilities
Accounts Payable
3
2
3
5
6
19
22
10
13
10
Accrued Liabilities
27
23
35
32
62
80
94
76
55
41
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
5
5
0
0
0
249
0
0
0
0
Other Current Liabilities
30
32
34
19
14
6
0
0
0
0
Total Current Liabilities
64
61
72
56
82
354
116
85
68
51
Long-Term Debt
129
243
244
245
247
0
0
0
0
0
Other Liabilities
212
188
165
120
104
218
346
353
276
216
Total Liabilities
405
N/A
492
+21%
481
-2%
421
-12%
433
+3%
572
+32%
462
-19%
438
-5%
344
-21%
267
-22%
Equity
Common Stock
0
0
0
0
0
0
0
0
0
0
Retained Earnings
1 786
1 868
2 021
2 118
1 424
1 865
2 309
2 833
3 201
3 477
Additional Paid In Capital
1 824
1 876
2 112
2 208
3 148
3 271
3 389
3 517
3 575
3 608
Other Equity
2
2
2
2
6
1
2
4
7
0
Total Equity
36
N/A
6
-82%
88
+1 277%
88
0%
1 718
+1 856%
1 405
-18%
1 077
-23%
680
-37%
367
-46%
131
-64%
Total Liabilities & Equity
442
N/A
499
+13%
569
+14%
509
-11%
2 150
+323%
1 977
-8%
1 539
-22%
1 117
-27%
711
-36%
398
-44%
Shares Outstanding
Common Shares Outstanding
131
135
160
160
174
177
180
186
189
191

See Also

Summary
NKTR intrinsic value, competitors valuation, and company profile.
DCF Valuation
NKTR stock valuation using Discount Cash Flow valuation method.
Relative Valuation
NKTR stock valuation using valuation multiples.
Wall Street Estimates
NKTR price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
NKTR stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 137,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.